0000899243-20-033481.txt : 20201211 0000899243-20-033481.hdr.sgml : 20201211 20201211062253 ACCESSION NUMBER: 0000899243-20-033481 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Webster Stephen W CENTRAL INDEX KEY: 0001438421 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 201382213 MAIL ADDRESS: STREET 1: C/O OPTIMER PHARMACEUTICALS, INC STREET 2: 101 HUDSON STREET CITY: SAN DIEGO STATE: CA ZIP: 07302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001438421 Webster Stephen W TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 31.83 2020-12-10 4 A 0 12100 0.00 A 2030-12-09 Common Stock 12100 12100 D 25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter. /s/ Margaret Siegel as Attorney-in-Fact 2020-12-10